William Caldwell, DO
Pain Medicine · Stony Brook, NYNPI 1487965778
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $439,977 of the $530,122 with a category attached, or 83.0%. Boston Scientific accounts for 66.7% of it on its own, with 26 other manufacturers making up the rest. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,475 payments — averaging $359.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$354K
- Relievant Medsystems, Inc.$143K
- Medtronic$27K
- Abbott$2K
- Nevro Corp.$705
- Stryker$468
- plus $3K from 21 others
Across 8 payments — averaging $2535.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$19K
- Boston Scientific$842
What the payments were for
- Consulting fees$14,7753%
- Speaking & faculty fees$439,97783%
- Travel & lodging$35,5607%
- Food & beverage$39,7608%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 731 | $353,796 |
| Relievant Medsystems, Inc. | 293 | $142,816 |
| Medtronic(2 entities) | 268 | $27,245 |
| Abbott | 72 | $1,985 |
| Nevro Corp. | 39 | $705 |
| Stryker | 5 | $468 |
| Painteq LLC | 5 | $449 |
| Globus Medical(2 entities) | 3 | $418 |
| Collegium Pharmaceutical, Inc. | 18 | $370 |
| Vertos Medical, Inc. | 3 | $353 |
| Vertiflex, Inc. | 5 | $247 |
| Spinal Simplicity, LLC | 2 | $233 |
| Stratus Medical, LLC | 2 | $167 |
| MML US, Inc. | 2 | $164 |
| Amgen | 7 | $131 |
| AbbVie | 5 | $115 |
| GRT US Holding, Inc. | 1 | $114 |
| Ferring Pharmaceuticals Inc. | 2 | $69 |
| Averitas Pharma Inc. | 2 | $55 |
| Stimwave Technologies Incorporated | 1 | $48 |
| Si-bone, Inc. | 2 | $44 |
| Johnson & Johnson | 1 | $32 |
| Bioventus LLC | 1 | $29 |
| Pfizer | 2 | $26 |
| Convatec Inc. | 1 | $22 |
| Avanos Medical | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$578,848
- WaveWriter Alpha Prime 16$52,121
- Superion Indirect Decompression System$11,635
- GENERAL - THERAPIES$6,940
- INTELLIS$5,848
- RESTORE$5,834
- ADAPTIVESTIM$4,785
- GENERAL PAIN MANAGEMENT$2,563
- Inflate FX$1,320
- PROCLAIM$792
- mild Device Kit$432
- SPECTRA WAVEWRITER$380
- INTELLIS ADAPTIVESTIM$338
- SPINEJACK$316
- SYNCHROMED$302
- PAINTEQ$278
- Bendini$265
- Senza Spinal Cord Stimulation System$233
- HA MINUTEMAN G3-R$176
- ACP$152
How this compares
$530,122 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 19 | $35,131 |
| NucyntaTapentadol Hcl | 19 | $32,430 |
| Pregabalin | 50 | $1,920 |
| Gabapentin | 68 | $989 |
| Oxycodone Hcl | 96 | $902 |
| Duloxetine Hcl | 33 | $840 |
| Celecoxib | 36 | $835 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $706 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $668 |
| Tizanidine Hcl | 38 | $598 |
| Tramadol Hcl | 56 | $281 |
| Methocarbamol | 20 | $186 |
| Meloxicam | 24 | $113 |
| Methylprednisolone | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta | $370 | $67,56138 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 pain medicine providers in New York.
Other pain medicine in Stony Brook
- Abhishek GuptaStony Brook$35K
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$614K
- Brian DurkinPort Jefferson$455K
- David SpinnerNew York$391K
- Grace FordeNew Hyde Park$355K
- Romanth WaghmaraeHamburg$158K
- Samuel BrownSouthold$147K
- Fred CohenBronx$141K
- Eric LeeNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.